These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37759937)

  • 1. Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation.
    Li Y; Srinath A; Alcazar-Felix RJ; Hage S; Bindal A; Lightle R; Shenkar R; Shi C; Girard R; Awad IA
    Brain Sci; 2023 Sep; 13(9):. PubMed ID: 37759937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin.
    Retta SF; Glading AJ
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):254-270. PubMed ID: 27639680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation Plays a Critical Role in Cerebral Cavernous Malformation Disease.
    Lai CC; Nelsen B; Frias-Anaya E; Gallego-Gutierrez H; Orecchioni M; Herrera V; Ortiz E; Sun H; Mesarwi OA; Ley K; Gongol B; Lopez-Ramirez MA
    Circ Res; 2022 Nov; 131(11):909-925. PubMed ID: 36285625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease.
    Retta SF; Perrelli A; Trabalzini L; Finetti F
    Methods Mol Biol; 2020; 2152():3-25. PubMed ID: 32524540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease.
    Perrelli A; Retta SF
    Free Radic Biol Med; 2021 Aug; 172():403-417. PubMed ID: 34175437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic signatures of individual cell types in cerebral cavernous malformation.
    Li Y; Girard R; Srinath A; Cruz DV; Ciszewski C; Chen C; Lightle R; Romanos S; Sone JY; Moore T; DeBiasse D; Stadnik A; Lee JJ; Shenkar R; Koskimäki J; Lopez-Ramirez MA; Marchuk DA; Ginsberg MH; Kahn ML; Shi C; Awad IA
    Cell Commun Signal; 2024 Jan; 22(1):23. PubMed ID: 38195510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common transcriptome, plasma molecules, and imaging signatures in the aging brain and a Mendelian neurovascular disease, cerebral cavernous malformation.
    Koskimäki J; Polster SP; Li Y; Romanos S; Srinath A; Zhang D; Carrión-Penagos J; Lightle R; Moore T; Lyne SB; Stadnik A; Piedad K; Cao Y; Shenkar R; Dimov AV; Hobson N; Christoforidis GA; Carroll T; Girard R; Awad IA
    Geroscience; 2020 Oct; 42(5):1351-1363. PubMed ID: 32556941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of familial and sporadic pediatric cerebral cavernous malformations and outcomes.
    Jaman E; Abdallah HM; Zhang X; Greene S
    J Neurosurg Pediatr; 2023 Oct; 32(4):506-513. PubMed ID: 37503918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies.
    Marchi S; Trapani E; Corricelli M; Goitre L; Pinton P; Retta SF
    Rare Dis; 2016; 4(1):e1142640. PubMed ID: 27141412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).
    Girard R; Li Y; Stadnik A; Shenkar R; Hobson N; Romanos S; Srinath A; Moore T; Lightle R; Shkoukani A; Akers A; Carroll T; Christoforidis GA; Koenig JI; Lee C; Piedad K; Greenberg SM; Kim H; Flemming KD; Ji Y; Awad IA
    Neurosurgery; 2021 Feb; 88(3):686-697. PubMed ID: 33469662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation.
    Weinsheimer S; Nelson J; Abla AA; Ko NU; Tsang C; Okoye O; Zabramski JM; Akers A; Zafar A; Mabray MC; Hart BL; Morrison L; McCulloch CE; Kim H;
    J Am Heart Assoc; 2023 Feb; 12(3):e027572. PubMed ID: 36695309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM).
    Benedetti V; Canzoneri R; Perrelli A; Arduino C; Zonta A; Brusco A; Retta SF
    Antioxidants (Basel); 2022 Jun; 11(7):. PubMed ID: 35883785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations.
    Globisch MA; Onyeogaziri FC; Smith RO; Arce M; Magnusson PU
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models.
    Phillips CM; Stamatovic SM; Keep RF; Andjelkovic AV
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating biomarkers in familial cerebral cavernous malformation.
    Lazzaroni F; Meessen JMTA; Sun Y; Lanfranconi S; Scola E; D'Alessandris QG; Tassi L; Carriero MR; Castori M; Marino S; Blanda A; Nicolis EB; Novelli D; Calabrese R; Agnelli NM; Bottazzi B; Leone R; Mazzola S; Besana S; Catozzi C; Nezi L; Lampugnani MG; Malinverno M; Grdseloff N; Rödel CJ; Rezai Jahromi B; Bolli N; Passamonti F; Magnusson PU; Abdelilah-Seyfried S; Dejana E; Latini R
    EBioMedicine; 2024 Jan; 99():104914. PubMed ID: 38113759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral Cavernous Malformations, Developmental Venous Anomaly, and Its Coexistence: A Review.
    Idiculla PS; Gurala D; Philipose J; Rajdev K; Patibandla P
    Eur Neurol; 2020; 83(4):360-368. PubMed ID: 32731220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome clarifies mechanisms of lesion genesis versus progression in models of Ccm3 cerebral cavernous malformations.
    Koskimäki J; Zhang D; Li Y; Saadat L; Moore T; Lightle R; Polster SP; Carrión-Penagos J; Lyne SB; Zeineddine HA; Shi C; Shenkar R; Romanos S; Avner K; Srinath A; Shen L; Detter MR; Snellings D; Cao Y; Lopez-Ramirez MA; Fonseca G; Tang AT; Faber P; Andrade J; Ginsberg M; Kahn ML; Marchuk DA; Girard R; Awad IA
    Acta Neuropathol Commun; 2019 Aug; 7(1):132. PubMed ID: 31426861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral cavernous malformation (CCM) disease: from monogenic forms to genetic susceptibility factors.
    Trapani E; Retta SF
    J Neurosurg Sci; 2015 Sep; 59(3):201-9. PubMed ID: 25896717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cavernous angiomas: deconstructing a neurosurgical disease.
    Awad IA; Polster SP
    J Neurosurg; 2019 Jul; 131(1):1-13. PubMed ID: 31261134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation.
    Globisch MA; Onyeogaziri FC; Jauhiainen S; Yau ACY; Orsenigo F; Conze LL; Arce M; Corada M; Smith RO; Rorsman C; Sundell V; Fernando D; Daniel G; Mattsson O; Savander H; Wanders A; Rezai Jahromi B; Laakso A; Niemelä M; Dejana E; Magnusson PU
    Blood; 2022 Nov; 140(20):2154-2169. PubMed ID: 35981497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.